beta 3 adrenoceptor agonists (Astellas)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namebeta 3 adrenoceptor agonists (Astellas)

Drug Alias NameFK-175

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta-3 adrenergic receptor agonists

TargetsBeta-3 adrenergic receptor

Therapy Area/IndicationsUrinary Bladder, Overactive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsUrinary Bladder, Overactive

ATC CodeN/A